SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,444,616 | -45.2% | 105,736 | -37.8% | 0.00% | -40.0% |
| Q2 2023 | $4,458,632 | -43.5% | 170,047 | -44.5% | 0.01% | -37.5% |
| Q1 2023 | $7,890,468 | +63.2% | 306,545 | +64.9% | 0.01% | +60.0% |
| Q4 2022 | $4,835,779 | +16.4% | 185,920 | +27.7% | 0.01% | 0.0% |
| Q3 2022 | $4,154,000 | -31.3% | 145,610 | -40.7% | 0.01% | -28.6% |
| Q2 2022 | $6,043,000 | +75.0% | 245,463 | +340.7% | 0.01% | +133.3% |
| Q4 2021 | $3,453,000 | -45.8% | 55,704 | -44.5% | 0.00% | -50.0% |
| Q3 2021 | $6,373,000 | -38.6% | 100,457 | -20.2% | 0.01% | -33.3% |
| Q2 2021 | $10,374,000 | -6.1% | 125,879 | -16.2% | 0.01% | -18.2% |
| Q1 2021 | $11,053,000 | +125.6% | 150,241 | +122.3% | 0.01% | +175.0% |
| Q4 2020 | $4,900,000 | – | 67,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |